Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings
In March 2010, the National Institute for Health and Clinical Excellence (NICE) published a clinical guideline outlining the best pharmacological treatments for adults with neuropathic pain who are being treated in non-specialist healthcare settings.1 Although the recommendations can be followed in hospital clinics other than pain or neurology clinics, they are most likely to be of the greatest benefit in primary care settings. The treatment of neuropathic pain in this context represents an important, but probably underestimated problem.
The NICE guideline uses the best available evidence on the effectiveness, cost effectiveness, and adverse reactions of the drugs that can be used in the treatment of neuropathic pain, the results of which are detailed in a practical guide for healthcare professionals to consider.1 By following the recommendations, it is hoped that there will be improvements in the identification and management of neuropathic pain in non-specialist settings.
Read review by Professor Blair H. Smith (registration and login to site required)
Related posts:
- Ottawa Panel Evidence-Based Clinical Practice Guidelines for the Management of Osteoarthritis in Adults Who Are Obese or Overweight
- Sustained behavioural change is needed for management of obesity
- Advantages of group treatment and structured exercise in promoting short-term weight loss and cardiovascular risk reduction in adults with central obesity.
- NICE recommends early referral for suspected RA
- Online Clinical Guidelines
Return to top of page